Galectin-1 (GAL-1) expression is a useful tool to differentiate between small cell osteosarcoma and Ewing sarcoma

Virchows Archiv

Volumn 462, Issue 6, 2013, Pages 665-671

  Machado, Isidro ^a   López Guerrero, José Antonio ^a   Navarro, Samuel ^b   Mayordomo, Empar ^b   Scotlandi, Katia ^c   Picci, Piero ^c   Llombart Bosch, Antonio ^b  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Chondrosarcoma; ESFT; GAL 1; Immunohistochemistry; Osteosarcoma

Indexed keywords

GALECTIN 1;

ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER TISSUE; CHONDROSARCOMA; CONTROLLED STUDY; DISEASE SEVERITY; EWING SARCOMA; EWING SARCOMA FAMILY OF TUMOR; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OSTEOBLAST; OSTEOBLASTOMA; OSTEOSARCOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMALL CELL OSTEOSARCOMA; TISSUE MICROARRAY; TUMOR VOLUME;

BONE NEOPLASMS; CELL COUNT; CHONDROBLASTOMA; CHONDROSARCOMA; DIAGNOSIS, DIFFERENTIAL; GALECTIN 1; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; RETROSPECTIVE STUDIES; SARCOMA, EWING; SARCOMA, SMALL CELL; TUMOR MARKERS, BIOLOGICAL;

EID: 84878942435     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-013-1423-3     Document Type: Article

References (23)

1. Banh A, Zhang J, Cao H, Bouley DM, Kwok S, Kong C, Giaccia AJ, Koong AC, Le QT (2011) Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis. Cancer Res 71(13):4423-4431
2. Satelli A, Rao US (2011) Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cells. Cancer Lett 301(1):38-46
3. Hittelet A, Legendre H, Nagy N, Bronckart Y, Pector JC, Salmon I, Yeaton P, Gabius HJ, Kiss R, Camby I (2003) Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration. Int J Cancer 103(3):370-379
4. Saussez S, Decaestecker C, Lorfevre F, Cucu DR, Mortuaire G, Chevalier D, Wacreniez A, Kaltner H, André S, Toubeau G, Camby I, Gabius HJ, Kiss R (2007) High level of galectin-1 expression is a negative prognostic predictor of recurrence in laryngeal squamous cell carcinomas. Int J Oncol 30(5):1109-1117
5. Laderach DJ, Gentilini L, Giribaldi L, Cardenas Delgado V, Nugnes L, Croci DO, Al Nakouzi N, Sacca P, Casas G, Mazza O, Shipp MA, Vazquez ES, Chauchereau A, Kutok JL, Rodig SJ, Elola MT, Compagno D, Rabinovich GA (2012) A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease. Cancer Res 73(1):86-93
6. Waalkes S, Merseburger AS, Simon A, Serth J, Kuczyk MA (2010) [Galectin expression in urological cancer. Diagnostic, prognostic and therapeutic potential]. Urologe A 49(3):387-391
7. Kim HJ, Jeon HK, Cho YJ, Park YA, Choi JJ, Do IG, Song SY, Lee YY, Choi CH, Kim TJ, Bae DS, Lee JW, Kim BG (2012) High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion. Eur J Cancer 48(12):1914-1921
8. Espelt MV, Croci DO, Bacigalupo ML, Carabias P, Manzi M, Elola MT, Muñoz MC, Dominici FP, Wolfenstein-Todel C, Rabinovich GA, Troncoso MF (2011) Novel roles of galectin-1 in hepatocellular carcinoma cell adhesion, polarization, and in vivo tumor growth. Hepatology 53(6):2097-2106
9. Wu H, Chen P, Liao R, Li YW, Yi Y, Wang JX, Sun TW, Zhou J, Shi YH, Yang XR, Jin JJ, Cheng YF, Fan J, Qiu SJ (2012) Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection. J Gastroenterol Hepatol 27(8):1312-1319
10. Mathieu V, de Lassalle EM, Toelen J, Mohr T, Bellahcène A, Van Goietsenoven G, Verschuere T, Bouzin C, Debyser Z, De Vleeschouwer S, Van Gool S, Poirier F, Castronovo V, Kiss R, Feron O (2012) Galectin-1 in melanoma biology and related neo-angiogenesis processes. J Invest Dermatol 132(9):2245-2254
11. Chen R, Pan S, Ottenhof NA, de Wilde RF, Wolfgang CL, Lane Z, Post J, Bronner MP, Willmann JK, Maitra A, Brentnall TA (2012) Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma. Cancer Biol Ther 13(10):899-907
12. Daroqui CM, Ilarregui JM, Rubinstein N, Salatino M, Toscano MA, Vazquez P, Bakin A, Puricelli L, Bal de Kier JE, Rabinovich GA (2007) Regulation of galectin-1 expression by transforming growth factor beta1 in metastatic mammary adenocarcinoma cells: implications for tumor-immune escape. Cancer Immunol Immunother 56(4):491-499
13. Wiest I, Seliger C, Walzel H, Friese K, Jeschke U (2005) Induction of apoptosis in human breast cancer and trophoblast tumor cells by galectin-1. Anticancer Res 25(3A):1575-1580
14. Gomez-Brouchet A, Mourcin F, Gourraud PA, Bouvier C, De Pinieux G, Le Guelec S, Brousset P, Delisle MB, Schiff C (2010) Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma. Hum Pathol 41(9):1220-1230
15. Llombart-Bosch A, Machado I, Navarro S, Bertoni F, Bacchini P, Alberghini M, Karzeladze A, Savelov N, Petrov S, Alvarado-Cabrero I, Mihaila D, Terrier P, Lopez-Guerrero JA, Picci P (2009) Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support. Virchows Arch 455(5):397-411
16. López-Guerrero JA, Machado I, Scotlandi K, Noguera R, Pellín A, Navarro S, Serra M, Calabuig-Fariñas S, Picci P, Llombart-Bosch A (2011) Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's sarcoma family of tumors. Int J Cancer 128(5):1139-1150
17. Machado I, López-Guerrero JA, Navarro S, Alberghini M, Scotlandi K, Picci P, Llombart-Bosch A (2012) Epithelial cell adhesion molecules and epithelial mesenchymal transition (EMT) markers in Ewing's sarcoma family of tumors (ESFTs). Do they offer any prognostic significance? Virchows Arch 461(3):333-337
18. Machado I, Alberghini M, Giner F, Corrigan M, O'Sullivan M, Noguera R, Pellin A, Bertoni F, Llombart-Bosch A (2010) Histopathological characterization of small cell osteosarcoma with immunohistochemistry and molecular genetic support. A study of 10 cases. Histopathology 57(1):162-167
19. Uma K, Cherian G, Nayak V, Patil S (2011) Small cell osteosarcoma of the mandible: case report and review of its diagnostic aspects. J Oral Maxillofac Pathol 15(3):330-334
20. Dragoescu E, Jackson-Cook C, Domson G, Massey D, Foster WC (2012) Small cell osteosarcoma with Ewing sarcoma breakpoint region 1 gene rearrangement detected by interphase fluorescence in situ hybridization. Ann Diagn Pathol(Sep 10)
21. Debelenko LV, McGregor LM, Shivakumar BR, Dorfman HD, Raimondi SC (2011) A novel EWSR1-CREB3L1 fusion transcript in a case of small cell osteosarcoma. Genes Chromosomes Cancer 50(12):1054-1062
22. Oshima Y, Kawaguchi S, Nagoya S, Wada T, Kokai Y, Ikeda T, Nogami S, Oya T, Hirayama Y (2004) Abdominal small round cell tumor with osteoid and EWS/FLI1. Hum Pathol 35(6):773-775
23. Noguera R, Navarro S, Triche TJ (1990) Translocation (11;22) in small cell osteosarcoma. Cancer Genet Cytogenet 45(1):121-124